Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Influenza

  Free Subscription


05.08.2019

2 Antiviral Res
1 Biochem Biophys Res Commun
1 Drugs
5 Epidemiol Infect
1 J Infect
3 J Virol
2 PLoS One
7 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Antiviral Res

  1. NG K, Raheem J, St Laurent CD, Marcet CT, et al
    Responses of human mast cells and epithelial cells following exposure to influenza A virus.
    Antiviral Res. 2019 Jul 23:104566. doi: 10.1016/j.antiviral.2019.104566.
    PubMed     Text format     Abstract available

  2. CHAUDHURI S, Symons JA, Deval J
    Innovation and trends in the development and approval of antiviral medicines: 1987-2017 and beyond.
    Antiviral Res. 2018 May 11. pii: S0166-3542(18)30180.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  3. JUNG Y, Kong B, Moon S, Yu SH, et al
    Envelope-deforming antiviral peptide derived from influenza virus M2 protein.
    Biochem Biophys Res Commun. 2019 Jul 30. pii: S0006-291X(19)31442.
    PubMed     Text format     Abstract available


    Drugs

  4. LAMB YN
    Cell-Based Quadrivalent Inactivated Influenza Virus Vaccine (Flucelvax((R)) Tetra/Flucelvax Quadrivalent((R))): A Review in the Prevention of Influenza.
    Drugs. 2019 Aug 2. pii: 10.1007/s40265-019-01176.
    PubMed     Text format     Abstract available


    Epidemiol Infect

  5. PRICE OH, Sullivan SG, Sutterby C, Druce J, et al
    Using routine testing data to understand circulation patterns of influenza A, respiratory syncytial virus and other respiratory viruses in Victoria, Australia.
    Epidemiol Infect. 2019;147:e221.
    PubMed     Text format     Abstract available

  6. WONG JY, Goldstein E, Fang VJ, Cowling BJ, et al
    Real-time estimation of the influenza-associated excess mortality in Hong Kong.
    Epidemiol Infect. 2019;147:e217.
    PubMed     Text format     Abstract available

  7. KOMADINA N, Sullivan SG, Kedzierska K, Quinones-Parra SM, et al
    Prior exposure to immunogenic peptides found in human influenza A viruses may influence the age distribution of cases with avian influenza H5N1 and H7N9 virus infections.
    Epidemiol Infect. 2019;147:e213.
    PubMed     Text format     Abstract available

  8. BODDINGTON NL, Warburton F, Zhao H, Andrews N, et al
    Influenza vaccine effectiveness against hospitalisation due to laboratory-confirmed influenza in children in England in the 2015-2016 influenza season - a test-negative case-control study.
    Epidemiol Infect. 2019;147:e201.
    PubMed     Text format     Abstract available

  9. MCHUGH L, Andrews RM, Leckning B, Snelling T, et al
    Baseline incidence of adverse birth outcomes and infant influenza and pertussis hospitalisations prior to the introduction of influenza and pertussis vaccination in pregnancy: a data linkage study of 78 382 mother-infant pairs, Northern Territory, Aus
    Epidemiol Infect. 2019;147:e233.
    PubMed     Text format     Abstract available


    J Infect

  10. YANG Y, Shen C, Li J, Zou R, et al
    Clinical and virological characteristics of human infections with H7N9 avian influenza virus in Shenzhen, China, 2013-2017.
    J Infect. 2019 Jul 30. pii: S0163-4453(19)30235.
    PubMed     Text format    


    J Virol

  11. BROECKER F, Zheng A, Suntrongwong N, Sun W, et al
    Extending the stalk enhances immunogenicity of the influenza virus neuraminidase.
    J Virol. 2019 Aug 2. pii: JVI.00840-19. doi: 10.1128/JVI.00840.
    PubMed     Text format     Abstract available

  12. RAMOS I, Smith G, Ruf-Zamojski F, Martinez-Romero C, et al
    Innate immune response to influenza virus at single-cell resolution in human epithelial cells revealed paracrine induction of interferon lambda 1.
    J Virol. 2019 Aug 2. pii: JVI.00559-19. doi: 10.1128/JVI.00559.
    PubMed     Text format     Abstract available

  13. MITRA S, Kumar D, Hu L, Sankaran B, et al
    Influenza A virus protein NS1 exhibits strain-independent conformational plasticity.
    J Virol. 2019 Aug 2. pii: JVI.00917-19. doi: 10.1128/JVI.00917.
    PubMed     Text format     Abstract available


    PLoS One

  14. ALESSANDRINI V, Anselem O, Girault A, Mandelbrot L, et al
    Does the availability of influenza vaccine at prenatal care visits and of immediate vaccination improve vaccination coverage of pregnant women?
    PLoS One. 2019;14:e0220705.
    PubMed     Text format     Abstract available

  15. KOLOSOVA NP, Ilyicheva TN, Danilenko AV, Bulanovich JA, et al
    Severe cases of seasonal influenza in Russia in 2017-2018.
    PLoS One. 2019;14:e0220401.
    PubMed     Text format     Abstract available


    Vaccine

  16. INNIS BL, Scorza FB, Blum JS, Jain VK, et al
    Convening on the influenza human viral challenge model for universal influenza vaccines, Part 2: Methodologic considerations.
    Vaccine. 2019;37:4830-4834.
    PubMed     Text format     Abstract available

  17. INNIS BL, Berlanda Scorza F, Blum JS, Jain VK, et al
    Meeting report: Convening on the influenza human viral challenge model for universal influenza vaccines, Part 1: Value; challenge virus selection; regulatory, industry and ethical considerations; increasing standardization, access and capacity.
    Vaccine. 2019;37:4823-4829.
    PubMed     Text format     Abstract available

  18. BELINGHERI M, De Vito G, Riva MA
    Italian midwives and influenza vaccination: problems in adherence and perception.
    Vaccine. 2019;37:4851.
    PubMed     Text format    

  19. ESTEBAN-VASALLO MD, Dominguez-Berjon MF, Garcia-Riolobos C, Zoni AC, et al
    Effect of mobile phone text messaging for improving the uptake of influenza vaccination in patients with rare diseases.
    Vaccine. 2019 Jul 25. pii: S0264-410X(19)30970.
    PubMed     Text format     Abstract available

  20. TATEISHI K, Fujihashi K, Yamamoto N, Hasegawa H, et al
    CpG ODN G9.1 as a novel nasal ODN adjuvant elicits complete protection from influenza virus infection without causing inflammatory immune responses.
    Vaccine. 2019 Jul 22. pii: S0264-410X(19)30923.
    PubMed     Text format     Abstract available

  21. MUNOZ FM, Anderson EJ, Bernstein DI, Harrison CJ, et al
    Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescents.
    Vaccine. 2019 Jul 30. pii: S0264-410X(19)31006.
    PubMed     Text format     Abstract available

  22. VENEREO-SANCHEZ A, Fulton K, Koczka K, Twine S, et al
    Characterization of influenza H1N1 Gag virus-like particles and extracellular vesicles co-produced in HEK-293SF.
    Vaccine. 2019 Jul 26. pii: S0264-410X(19)30955.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: